Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+. (2011). Farmeconomia. Health Economics and Therapeutic Pathways, 12(2), 77-85. https://doi.org/10.7175/fe.v12i2.73